Caitlin Costello, MD, discusses treatment selection considerations in multiple myeloma.
Caitlin Costello, MD, hematologist/medical oncologist, assistant professor of medicine, University of California, San Diego Health, discusses treatment selection considerations in multiple myeloma.
Patient- and disease-specific disease factors should be considered when selecting the optimal up-front therapy for a patient with newly diagnosed multiple myeloma, Costello says.
Age is solely a number and should not be the only consideration when it comes to treatment selection, Costello explains.
Performance status may inform what therapies a patient will tolerate and how aggressively they should be treated, Costello says.
Furthermore, the patient’s comorbidities, social support system, and ability to travel to the infusion center should also be determined early on in treatment selection, says Costello.
Additionally, deciding whether a patient is eligible to receive oral vs infusional therapy is needed, concludes Costello.